tradingkey.logo

Sight Sciences Inc

SGHT

3.370USD

+0.100+3.06%
交易中 美东报价延迟15分钟
173.14M总市值
亏损市盈率 TTM

Sight Sciences Inc

3.370

+0.100+3.06%
关于 Sight Sciences Inc 公司
Sight Sciences, Inc. 是一家眼科技术公司。该公司专注于开发和商业化用于治疗常见眼病的手术和非手术技术。该公司通过两个部门运营:手术青光眼和干眼症。手术青光眼部门的产品组合包括 OMNI 手术系统,这是一种无植入体青光眼手术技术,用于降低原发性开角型青光眼成年患者的眼压,以及 SION 手术器械,这是一种用于眼科手术程序以切除小梁网的手动操作设备。干眼症部门的产品组合包括适用于眼科医生和验光师的 TearCare 系统 (TearCare)。TearCare 是一种可穿戴的眼睑技术,可为因睑板腺功能障碍而患有蒸发性干眼症的成年患者的眼睑睑板腺提供有针对性的可调节热量。
公司简介
公司代码SGHT
公司名称Sight Sciences Inc
上市日期Jul 15, 2021
CEOMr. Paul Badawi
员工数量216
证券类型Ordinary Share
年结日Jul 15
公司地址4040 Campbell Ave,
城市MENLO PARK
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编94025
电话14158890550
网址https://www.sightsciences.com/
公司代码SGHT
上市日期Jul 15, 2021
CEOMr. Paul Badawi
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.27M
-0.45%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
1.99M
+9.78%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.68M
+2.09%
Mr. Matthew W. Link
Mr. Matthew W. Link
Chief Commercial Officer
Chief Commercial Officer
832.29K
-0.58%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
94.77K
+373.83%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
80.30K
-19.35%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
75.35K
+69.71%
Ms. Catherine Mazzacco
Ms. Catherine Mazzacco
Independent Director
Independent Director
68.44K
+82.56%
Ms. Brenda Becker
Ms. Brenda Becker
Independent Director
Independent Director
48.09K
+156.16%
Mr. Jeremy Bragg Hayden, J.D.
Mr. Jeremy Bragg Hayden, J.D.
Chief Legal Officer
Chief Legal Officer
33.81K
-21.32%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.27M
-0.45%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
1.99M
+9.78%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.68M
+2.09%
Mr. Matthew W. Link
Mr. Matthew W. Link
Chief Commercial Officer
Chief Commercial Officer
832.29K
-0.58%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
94.77K
+373.83%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
80.30K
-19.35%
收入明细
暂无数据
暂无数据
业务
地区
暂无数据
股东统计
更新时间: 5月22日 周四
更新时间: 5月22日 周四
持股股东
股东类型
持股股东
持股股东
占比
Badawi (Paul)
10.20%
Allegro Investment, Inc.
9.84%
KCK, Ltd.
8.46%
Long Focus Capital Management LLC
6.05%
BlackRock Institutional Trust Company, N.A.
4.09%
Other
61.36%
持股股东
持股股东
占比
Badawi (Paul)
10.20%
Allegro Investment, Inc.
9.84%
KCK, Ltd.
8.46%
Long Focus Capital Management LLC
6.05%
BlackRock Institutional Trust Company, N.A.
4.09%
Other
61.36%
股东类型
持股股东
占比
Hedge Fund
21.82%
Individual Investor
21.19%
Investment Advisor
20.44%
Investment Advisor/Hedge Fund
7.29%
Research Firm
1.10%
Pension Fund
0.15%
Bank and Trust
0.08%
Other
27.93%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
210
37.29M
72.12%
-12.04M
2025Q1
220
37.28M
72.25%
-12.21M
2024Q4
223
37.28M
73.67%
-9.99M
2024Q3
223
36.71M
73.32%
-14.98M
2024Q2
223
36.40M
73.23%
-17.15M
2024Q1
223
36.63M
74.26%
-15.04M
2023Q4
226
36.66M
74.98%
-10.49M
2023Q3
225
39.02M
80.44%
-12.17M
2023Q2
222
40.39M
83.26%
-10.75M
2023Q1
206
40.37M
83.63%
-9.62M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Badawi (Paul)
5.30M
10.24%
-142.97K
-2.63%
Apr 09, 2025
Allegro Investment, Inc.
5.09M
9.84%
+1.06M
+26.47%
Mar 12, 2025
KCK, Ltd.
4.37M
8.46%
-271.89K
-5.85%
Dec 31, 2024
Long Focus Capital Management LLC
3.13M
6.05%
+567.50K
+22.18%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.12M
4.09%
-48.79K
-2.25%
Mar 31, 2025
Encrantz (Staffan)
1.99M
3.85%
+177.51K
+9.78%
Jun 06, 2025
The Vanguard Group, Inc.
1.70M
3.28%
+63.19K
+3.87%
Mar 31, 2025
Badawi (David)
1.64M
3.18%
-39.33K
-2.34%
Apr 09, 2025
Prosight Capital
969.29K
1.87%
+60.44K
+6.65%
Mar 31, 2025
B Group, Inc.
833.60K
1.61%
+204.23K
+32.45%
Mar 31, 2025
查看更多
持股ETF
更新时间: 8月2日 周六
更新时间: 8月2日 周六
机构名称
占比
iShares Micro-Cap ETF
0.04%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
ProShares Hedge Replication ETF
0.01%
ProShares UltraPro Russell2000
0.01%
iShares US Small-Cap Equity Factor ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
iShares Morningstar Small-Cap ETF
0%
查看更多
iShares Micro-Cap ETF
占比0.04%
iShares Russell 2000 ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%
ProShares Hedge Replication ETF
占比0.01%
ProShares UltraPro Russell2000
占比0.01%
iShares US Small-Cap Equity Factor ETF
占比0.01%
Avantis US Small Cap Equity ETF
占比0.01%
iShares Morningstar Small-Cap ETF
占比0%
分红派息
近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
tradingkey.logo
tradingkey.logo
日内数据由路孚特(Refinitiv)提供,并受使用条款约束。历史及当前收盘数据均由路孚特提供。所有报价均以当地交易所时间为准。美股报价的实时最后成交数据仅反映通过纳斯达克报告的交易。日内数据延迟至少15分钟或遵循交易所要求。
* 参考、分析和交易策略由第三方提供商Trading Central提供,观点基于分析师的独立评估和判断,未考虑投资者的投资目标和财务状况。
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有
KeyAI